TITLE:
Major Depressive Disorder Study In Adults

CONDITION:
Major Depressive Disorder

INTERVENTION:
paroxetine CR

SUMMARY:

      A study to obtain safety and tolerability data
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Inclusion Criteria:

          -  Patient must have primary diagnosis of Major Depressive Disorder (MDD).

          -  Discontinued a selective serotonin reuptake inhibitor (SSRI)or
             serotonin-norepinephrine reuptake inhibitor (SNRI) regimen due to intolerability.

          -  Minimum time frame between last dose of previous antidepressant and initiation of
             study drug is one week.

          -  Maximum time frame between last dose of prior antidepressant and initiation of study
             drug is 2 months.

        Exclusion Criteria:

          -  Patient has previously been treated with the study drug.

          -  Is experiencing an adverse event attributed to previous SSRI/SNRI use that has not
             been resolved at least one week prior to Baseline Visit.

          -  Has a history of seizure disorder.

          -  Has met criteria for substance abuse or dependence within 6 months prior to Baseline
             Visit.

          -  Currently using an antidepressant.

          -  Currently pregnant.
      
